- Home
- WPP vs HALO Comparison
WPP vs HALO Comparison
Compare WPP & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPP
- HALO
- Stock Information
- Founded
- WPP 1985
- HALO 1998
- Country
- WPP United Kingdom
- HALO United States
- Employees
- WPP N/A
- HALO N/A
- Industry
- WPP Advertising
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WPP Consumer Discretionary
- HALO Health Care
- Exchange
- WPP Nasdaq
- HALO Nasdaq
- Market Cap
- WPP 5.1B
- HALO 7.6B
- IPO Year
- WPP N/A
- HALO N/A
- Fundamental
- Price
- WPP $24.38
- HALO $66.16
- Analyst Decision
- WPP Sell
- HALO Buy
- Analyst Count
- WPP 1
- HALO 11
- Target Price
- WPP N/A
- HALO $73.00
- AVG Volume (30 Days)
- WPP 529.7K
- HALO 2.1M
- Earning Date
- WPP 08-07-2025
- HALO 11-03-2025
- Dividend Yield
- WPP 8.69%
- HALO N/A
- EPS Growth
- WPP 86.47
- HALO 68.93
- EPS
- WPP 0.47
- HALO 4.37
- Revenue
- WPP $19,423,208,660.00
- HALO $1,178,672,000.00
- Revenue This Year
- WPP N/A
- HALO $32.57
- Revenue Next Year
- WPP $0.58
- HALO $23.77
- P/E Ratio
- WPP $51.33
- HALO $15.32
- Revenue Growth
- WPP N/A
- HALO 34.97
- 52 Week Low
- WPP $22.42
- HALO $42.01
- 52 Week High
- WPP $57.37
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- WPP 49.87
- HALO 39.00
- Support Level
- WPP $23.12
- HALO $65.16
- Resistance Level
- WPP $24.26
- HALO $67.50
- Average True Range (ATR)
- WPP 0.67
- HALO 1.93
- MACD
- WPP 0.14
- HALO -0.17
- Stochastic Oscillator
- WPP 66.72
- HALO 29.36
About WPP WPP plc
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.